Slate Medicines | $130,000,000 | (Feb 25, 2026)
Letter AI | $40,000,000 | (Feb 25, 2026)
Subject | $28,000,000 | (Feb 25, 2026)
Mixpanel
United States
- San Francisco, CA
- 16/11/2021
- Series C
- $200,000,000
Mixpanel is a leading product analytics software company, currently helping the world answer 81 million product questions every year. Our pioneering event-based tracking solution gives product teams the ability to gain insights into how to best acquire, convert, and retain their users across web and mobile platforms.
Powerful, flexible, and easy-to-use, Mixpanel enables teams to learn from their user data and innovate rapidly in creating winning products. Today, we serve nearly 6,000 paying customers through seven offices globally in our quest to provide the most in-depth product analytics that everyone can use and trust.
Visit: www.mixpanel.com.
- Industry Software Development
- Website https://mixpanel.com/
- LinkedIn https://www.linkedin.com/company/mixpanel-inc-/
Related People
Amir MovafaghiFounder
United States -
San Francisco Bay Area
I am indebted to my managers, colleagues and friends who were generous with their knowledge and time along the way.
KrisAtWork | $3,000,000 | (Feb 25, 2026)
Centauri Therapeutics Limited | $8,107,170 | (Feb 25, 2026)
Slang AI | $36,000,000 | (Feb 25, 2026)
Brilliant Harvest Inc. | $4,000,000 | (Feb 25, 2026)
Koah | $20,500,000 | (Feb 25, 2026)
Nimble | $47,000,000 | (Feb 25, 2026)
General Magic | $7,200,000 | (Feb 25, 2026)
Circadian Risk Inc. | $6,000,000 | (Feb 25, 2026)
Neural Earth | $9,300,000 | (Feb 25, 2026)
Jampack AI | $3,200,000 | (Feb 25, 2026)